You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Drug safety profile

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participants Trial in Groningen (AB521, Placebo, Midazolam)

Recruiting
  • Healthy Participants
  • Groningen, Netherlands
    Investigational Site
Dec 6, 2022

Cancer, Advanced Cancer, Advanced Solid Tumor Trial (Drug-Drug Interaction Profile, Drug-Gene Interaction Profile, Standard of

Not yet recruiting
  • Cancer
  • +2 more
  • Drug-Drug Interaction Profile
  • +2 more
  • (no location specified)
Dec 8, 2021

Psoriasis Trial in Fargo, Philadelphia (Drug (SFA002) Vitamin D, Magnesium, Drug (SFA002) Vitamin D, Magnesium and Propionate)

Recruiting
  • Psoriasis
  • Drug (SFA002) Vitamin D, Magnesium
  • Drug (SFA002) Vitamin D, Magnesium and Propionate
  • Fargo, North Dakota
  • +1 more
Dec 9, 2022

Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papilloma Virus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Medical Device Derived Pharmacokinetic Parameters for Vancomycin

Not yet recruiting
  • Infection, Bacterial
  • +7 more
  • Drug Infusion Pump Monitoring
  • London, United Kingdom
    St Georges University Hospitals NHS Foundation Trust
Jul 10, 2023

IVF Trial in Anand (OPT-IVF dosage)

Completed
  • IVF
  • OPT-IVF dosage
  • Anand, Gujrat, India
    Akansha Hospital and Research Institute
Jul 20, 2022

Polypharmacy Trial in Swansea (Adverse Drug Reaction ADRe Profile for Polypharmacy)

Completed
Has Results
  • Polypharmacy
  • Adverse Drug Reaction ADRe Profile for Polypharmacy
  • Swansea, United Kingdom
    Swansea University
Aug 16, 2021

Polypharmacy Trial in Newport (Adverse Drug Reaction (ADRe) Profile)

Completed
  • Polypharmacy
  • Adverse Drug Reaction (ADRe) Profile
  • Newport, Gwent, United Kingdom
    Aneurin Bevan Health Board
Sep 29, 2021

Total Knee Arthoplasty Trial in Philadelphia (procedure, drug, device)

Enrolling by invitation
  • Total Knee Arthoplasty
  • total knee arthroplasty
  • +3 more
  • Philadelphia, Pennsylvania
    Rothman Orthopaedic Institute
Jun 17, 2022

Acute Pain Trial in Cincinnati (ETR028, ETR029, [ETR028 + ETR029] or HCBT)

Recruiting
  • Acute Pain
  • ETR028, ETR029, [ETR028 + ETR029] or HCBT
  • Cincinnati, Ohio
    Medpace
Oct 7, 2022

Vascular Diseases, Kidney Diseases Trial (Advance PTX, Advance LP (Low Profile), Paclitaxel (PTX))

Completed
  • Vascular Diseases
  • Kidney Diseases
  • Advance PTX
  • +2 more
  • (no location specified)
Dec 29, 2021

EZETROL® Re-examination Study (MK0653-175)(COMPLETED)

Completed
Has Results
  • Hypercholesterolemia
    • (no location specified)
    Feb 7, 2022

    Elonva (Corifollitropin Alfa) in General Practice (P08165)

    Completed
    • Infertility, Female
    • corifollitropin alfa
    • (no location specified)
    Feb 1, 2022

    Cozaar XQ Re-examination Study (MK-0954-349)

    Completed
    • Hypertension
    • (no location specified)
    Feb 7, 2022

    Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

    Recruiting
    • Metastatic or Locally Advanced Unresectable Solid Tumors
    • Houston, Texas
    • +4 more
    Jul 7, 2022

    Vytorin Reexamination Study (0653A-174)

    Completed
    Has Results
    • Primary Hypercholesterolemia and Homozygous Familial Hypercholesterolemia (HoFH)
      • (no location specified)
      Feb 7, 2022

      Epilepsy, Alzheimer, Epilepsy Intractable Trial in Lincoln (NPT 2042 (bumetanide analog) or Matching Placebo)

      Not yet recruiting
      • Epilepsy
      • +2 more
      • NPT 2042 (bumetanide analog) or Matching Placebo
      • Lincoln, Nebraska
        Celerion
      Aug 12, 2022

      Called UV Population, to Learn More About Safety of Study Drug

      Recruiting
      • Contrast Enhanced X-ray Based Examination
      • Iopromide (Ultravist, BAY86-4877)
      • Multiple Locations, Germany
        Many Locations
      Jul 26, 2022

      Surgery Trial in Chicago (procedure, diagnostic test, other)

      Recruiting
      • Surgery
      • Routine Elective Surgery- In patient or out patient elective surgery
      • +2 more
      • Chicago, Illinois
        University Of Chicago Medicine Comprehensive Cancer Center
      Jan 7, 2022

      PKPD of Rocuronium and Sugammadex Profile in Pediatric Patients

      Completed
      • General Anesthetic Drug Adverse Reaction
      • Sugammadex Injection
      • Poznan, Grand Poland, Poland
        Alicja Bartkowska-Sniatkowska
      Apr 18, 2021

      Healthy Volunteers Trial in Miami (CTP-543)

      Completed
      • Healthy Volunteers
      • Miami, Florida
        Clinical Pharmacology of Miami
      Jul 14, 2021

      Drug Toxicity Trial in Durham (Placebo, MW151, 10mg, MW151, 20mg)

      Completed
      • Drug Toxicity
      • Placebo
      • +5 more
      • Durham, North Carolina
        Duke Clinical Research Institute
      Dec 3, 2021

      HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated

      Recruiting
      • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
      • +11 more
      • NavDx HPV ctDNA Testing
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Jul 6, 2022

      Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma Trial in Belgium, United States (Bapotulimab (BAY1905254),

      Active, not recruiting
      • Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma
      • Bapotulimab (BAY1905254)
      • Bapotulimab (BAY1905254) + Pembrolizumab
      • Tucson, Arizona
      • +7 more
      Jan 12, 2023